Louis Lacasse, MBA General Partner
Mr. Lacasse joined GeneChem at its inception in 1997. Prior to that, he was Vice-President of Healthcare and Biotechnology at Sofinov, a wholly owned venture capital subsidiary of Caisse de dépôt et placement du Québec. In total, he spent ten years with the Caisse where he was responsible for numerous investments in small and medium sized businesses in cutting-edge industries such as biotechnology, software and telecommunications. Mr. Lacasse has been involved in a number of very successful investments in companies such as BioChem Pharma inc., Axcan Pharma inc., and Neurocrine Biosciences inc. Mr. Lacasse is or has been a member of the board of directors of several companies including BioChem Pharma inc., Axcan Pharma inc. and Metrowerks inc. He has held positions with the Bank of Montreal and with the "Centre de développement technologique" of École Polytechnique de Montréal. Mr. Lacasse obtained a Bachelor's degree in finance from the École des Hautes Études Commerciales ("HEC") and a M.B.A. from McGill University. In 2008, he became a member of the Institute of Corporate Directors.